Caitong International Asset Management Co., LTD Tarsus Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $140 Billion
- Q2 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 139 shares of TARS stock, worth $9,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139Holding current value
$9,650% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
217Shares Held
46.9MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$227 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$216 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$207 Million5.63% of portfolio
-
Jennison Associates LLC2.6MShares$181 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$170 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.85B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...